Cancer ATF4-mediated CD58 endocytosis impairs anti-tumor immunity and immunotherapy
Abstract Co-stimulatory molecules are imperative for CD8+ T cells to eliminate target cell and maintain sustained cytotoxicity. Despite an advanced understanding of the co-stimulatory molecules deficiency that results in tumor escape, the tumor cell-intrinsic mechanisms that regulate co-stimulatory...
Saved in:
| Main Authors: | Hanyi Zeng, Jiaping Yu, Haijian Wang, Mengying Shen, Xuejing Zou, Ziyong Zhang, Li Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-025-06245-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy
by: Yibin Lin, et al.
Published: (2025-03-01) -
Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity
by: Antonia Stubenvoll, et al.
Published: (2025-04-01) -
Calcium-dependent oligomerization of scavenger receptor CD163 facilitates the endocytosis of ligands
by: Hua Xu, et al.
Published: (2025-07-01) -
A potential prognostic marker for hematologic neoplasms: CD58
by: Jiajia Cao, et al.
Published: (2025-04-01) -
Virus Entry by Endocytosis
by: Anthony V. Nicola, et al.
Published: (2013-01-01)